Overall, the common mutation site of NRAS gene was located in exons 2 and 3, with 28.6% (10/35) [18, 24, 25] and 48.6% (17/35) [18, 20, 24, 25] of CRC patient (Table 3). The gene discussed is NRAS; the disease is colorectal carcinoma.